Systemic inflammatory profiles and their relationships with demographic, behavioural and clinical features in acute low back pain

Brain, Behavior, and Immunity

Volumn 60, Issue , 2017, Pages 84-92

  Klyne, David M ^a   Barbe, Mary F ^b   Hodges, Paul W ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C reactive protein (CRP); Interleukin 1 (IL 1 ); Interleukin 6 (IL 6); Low back pain (LBP); Pro inflammatory cytokines; Tumor necrosis factor (TNF)

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; AUTACOID; BIOLOGICAL MARKER;

ADULT; ARTICLE; BEHAVIOR; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISABILITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SLEEP QUALITY; VISUAL ANALOG SCALE; ACUTE DISEASE; BLOOD; METABOLISM; MIDDLE AGED;

ACUTE DISEASE; ADULT; BIOMARKERS; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LOW BACK PAIN; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85007453210     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.10.003     Document Type: Article

References (125)

1. Abbadie, C., Chemokines, chemokine receptors and pain. Trends Immunol. 26:10 (2005), 529–534.
2. Achur, R.N., Freeman, W.M., Vrana, K.E., Circulating cytokines as biomarkers of alcohol abuse and alcoholism. J. Neuroimmune Pharmacol. 5:1 (2010), 83–91.
3. Aderka, D., Le, J.M., Vilcek, J., Il-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human-monocytes, U937 cells, and in mice. J. Immunol. 143:11 (1989), 3517–3523.
4. Adser, H., Wojtaszewski, J.F.P., Jakobsen, A.H., Kiilerich, K., Hidalgo, J., Pilegaard, H., Interleukin-6 modifies mRNA expression in mouse skeletal muscle. Acta Physiol. 202:2 (2011), 165–173.
5. Allin, K.H., Nordestgaard, B.G., Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit. Rev. Clin. Lab. Sci. 48:4 (2011), 155–170.
6. Allin, K.H., Nordestgaard, B.G., Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit. Rev. Clin. Lab. Sci. 48:4 (2011), 155–170.
7. Backhaus, J., Junghanns, K., Broocks, A., Riemann, D., Hohagen, F., Test-retest reliability and validity of the Pittsburgh sleep quality index in primary insomnia. J. Psychosom. Res. 53:3 (2002), 737–740.
8. Bermudez, E.A., Rifai, N., Buring, J., Manson, J.E., Ridker, P.A., Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler. Thromb. Vasc. Biol. 22:10 (2002), 1668–1673.
9. Bhardwaj, N., Santhanam, U., Lau, L.L., Tatter, S.B., Ghrayeb, J., Rivelis, M., Steinman, R.M., Sehgal, P.B., May, L.T., IL-6/IFN-beta 2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources. J. Immunol. 143:7 (1989), 2153–2159.
10. Bienvenu, J., Monneret, G., Fabien, N., Revillard, J.P., The clinical usefulness of the measurement of cytokines. Clin. Chem. Lab. Med. 38:4 (2000), 267–285.
11. Biffl, W.L., Moore, E.E., Moore, F.A., Peterson, V.M., Interleukin-6 in the injured patient marker of injury or mediator of inflammation?. Ann. Surg. 224:5 (1996), 647–664.
12. Black, S., Kushner, I., Samols, D., C-reactive protein. J. Biol. Chem. 279:47 (2004), 48487–48490.
13. Boonstra, A.M., Preuper, H.R.S., Balk, G.A., Stewart, R.E., Cut-off points for mild, moderate, and severe pain on the visual analogue scale for pain in patients with chronic musculoskeletal pain. Pain 155:12 (2014), 2545–2550.
14. Buckley, T.M., Schatzberg, A.F., On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J. Clin. Endocrinol. Metab. 90:5 (2005), 3106–3114.
15. Buvanendran, A., Kroin, J.S., Berger, R.A., Hallab, N.J., Saha, C., Negrescu, C., Moric, M., Caicedo, M.S., Tuman, K.J., Upregulation of prostaglandin E-2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology 104:3 (2006), 403–410.
16. Buysse, D.J., Reynolds, C.F., Monk, T.H., Berman, S.R., Kupfer, D.J., The Pittsburgh sleep quality index – a new instrument for psychiatric practice and research. Psychiatry Res. 28:2 (1989), 193–213.
17. Carp, S.J., Barbe, M.F., Winter, K.A., Amin, M., Barr, A.E., Inflammatory biomarkers increase with severity of upper-extremity overuse disorders. Clin. Sci. (Lond) 112:5 (2007), 305–314.
18. Carp, S., Barr, A.E., Barbe, M.F., Serum biomarkers as signals for risk and severity of work-related musculoskeletal injury. Biomarkers Med. 2:1 (2008), 67–79.
19. Carpenter, J.S., Andrykowski, M.A., Psychometric evaluation of the Pittsburgh sleep quality index. J. Psychosom. Res. 45:1 (1998), 5–13.
20. Castell, J.V., Geiger, T., Gross, V., Andus, T., Walter, E., Hirano, T., Kishimoto, T., Heinrich, P.C., Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur. J. Biochem. 177:2 (1988), 357–361.
21. Cevenini, E., Caruso, C., Candore, G., Capri, M., Nuzzo, D., Duro, G., Rizzo, C., Colonna-Romano, G., Lio, D., Di, Carlo D., Palmas, M.G., Scurti, M., Pini, E., Franceschi, C., Vasto, S., Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr. Pharm. Des. 16:6 (2010), 609–618.
22. Cevenini, E., Monti, D., Franceschi, C., Inflamm-ageing. Curr. Opin. Clin. Nutr. Metab. Care 16:1 (2013), 14–20.
23. Chennaoui, M., Sauvet, F., Drogou, C., Van Beers, P., Langrume, C., Guillard, M., Gourby, B., Bourrilhon, C., Florence, G., Gomez-Merino, D., Effect of one night of sleep loss on changes in tumor necrosis factor alpha (TNF-alpha) levels in healthy men. Cytokine 56:2 (2011), 318–324.
24. Cottam, D.R., Mattar, S.G., Barinas-Mitchell, E., Eid, G., Kuller, L., Kelley, D.E., Schauer, P.R., The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes. Surg. 14:5 (2004), 589–600.
25. Crews, F.T., Bechara, R., Brown, L.A., Guidot, D.M., Mandrekar, P., Oak, S., Qin, L.Y., Szabo, G., Wheeler, M., Zou, J., Cytokines and alcohol. Alcohol. Clin. Exp. Res. 30:4 (2006), 720–730.
26. Cruickshank, A.M., Fraser, W.D., Burns, H.J.G., Vandamme, J., Shenkin, A., Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin. Sci. 79:2 (1990), 161–165.
27. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9:1 (2008), 46–57.
28. Darnall, B.D., Aickin, M., Zwickey, H., Pilot study of inflammatory responses following a negative imaginal focus in persons with chronic pain: analysis by sex/gender. Gend. Med. 7:3 (2010), 247–260.
29. Della Vedova, C., Cathcart, S., Dohnalek, A., Lee, V., Hutchinson, M.R., Immink, M.A., Hayball, J., Peripheral interleukin-1B levels are elevated in chronic tension-type headache patients. Pain Res. Manage. 18:6 (2013), 301–306.
30. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctot, K.L., A meta-analysis of cytokines in major depression. Biol. Psychiatry 67:5 (2010), 446–457.
31. Edwards, R.R., Kronfli, T., Haythornthwaite, J.A., Smith, M.T., McGuire, L., Page, G.G., Association of catastrophizing with interleukin-6 responses to acute pain. Pain 140:1 (2008), 135–144.
32. Eisenhardt, S.U., Habersberger, J., Murphy, A., Chen, Y.C., Woollard, K.J., Bassler, N., Qian, H.W., von zur Muhlen, C., Hagemeyer, C.E., Ahrens, I., Chin-Dusting, J., Bobik, A., Peter, K., Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ. Res. 105:2 (2009), U128–U155.
33. Eisenhardt, S.U., Habersberger, J., Peter, K., Monomeric C-reactive protein generation on activated platelets: the missing link between inflammation and atherothrombotic risk. Trends Cardiovasc. Med. 19:7 (2009), 232–237.
34. Eisenhardt, S.U., Thiele, J.R., Bannasch, H., Stark, G.B., Peter, K., C-reactive protein How conformational changes influence inflammatory properties. Cell Cycle 8:23 (2009), 3885–3892.
35. Ershler, W.B., Keller, E.T., Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 51 (2000), 245–270.
36. Esser, N., Legrand-Poels, S., Piette, J., Scheen, A.J., Paquot, N., Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 105:2 (2014), 141–150.
37. Fasick, V., Spengler, R.N., Samankan, S., Nader, N.D., Ignatowski, T.A., The hippocampus and TNF: common links between chronic pain and depression. Neurosci. Biobehav. Rev. 53 (2015), 139–159.
38. Felger, J.C., Lotrich, F.E., Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 246 (2013), 199–229.
39. Feng, Y., Ju, H., Yang, B.X., An, H.Y., Effects of a selective cyclooxygenase-2 inhibitor on postoperative inflammatory reaction and pain after total knee replacement. J. Pain 9:1 (2008), 45–52.
40. Foster, K.D., Conn, C.A., Kluger, M.J., Fever, tumor-necrosis-factor, and interleukin-6 in young, mature, and aged Fischer 344 rats. Am. J. Physiol. 262:2 (1992), R211–R215.
41. Ganter, U., Arcone, R., Toniatti, C., Morrone, G., Ciliberto, G., Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J. 8:12 (1989), 3773–3779.
42. Gebhard, F., Pfetsch, H., Steinbach, G., Strecker, W., Kinzl, L., Bruckner, U.B., Is interleukin 6 an early marker of injury severity following major trauma in humans?. Arch. Surg. 135:3 (2000), 291–295.
43. George, S.Z., Valencia, C., Beneciuk, J.M., A psychometric investigation of fear-avoidance model measures in patients with chronic low back pain. J. Orthop. Sports Phys. Ther. 40:4 (2010), 197–205.
44. Giannoudis, P.V., Hildebrand, F., Pape, H.C., Inflammatory serum markers in patients with multiple trauma. Can they predict outcome?. J. Bone Joint Surg. Br. 86:3 (2004), 313–323.
45. Griselli, M., Herbert, J., Hutchinson, W.L., Taylor, K.M., Sohail, M., Krausz, T., Pepys, M.B., C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J. Exp. Med. 190:12 (1999), 1733–1740.
46. Haack, M., Sanchez, E., Mullington, J.M., Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 30:9 (2007), 1145–1152.
47. Heffner, K.L., France, C.R., Trost, Z., Ng, H.M., Pigeon, W.R., Chronic low back pain, sleep disturbance, and interleukin-6. Clin. J. Pain 27:1 (2011), 35–41.
48. Heikkila, K., Ebrahim, S., Rumley, A., Lowe, G., Lawlor, D.A., Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British women's heart and health study. Cancer Epidemiol. Biomark. Prev. 16:6 (2007), 1155–1159.
49. Heinrich, P.C., Castell, J.V., Andus, T., Interleukin-6 and the acute phase response. Biochem. J. 265:3 (1990), 621–636.
50. Hernandez, M.E., Becerril, E., Perez, M., Leff, P., Anton, B., Estrada, S., Estrada, I., Sarasa, M., Serrano, E., Pavon, L., Proinflammatory cytokine levels in fibromyalgia patients are independent of body mass index. BMC Res. Notes, 3(1), 2010, 156.
51. Hogan, D., Morrow, J.D., Smith, E.M., Opp, M.R., Interleukin-6 alters sleep of rats. J. Neuroimmunol. 137:1–2 (2003), 59–66.
52. Irwin, M., Effects of sleep and sleep loss on immunity and cytokines. Brain Behav. Immun. 16:5 (2002), 503–512.
53. Irwin, M.R., Wang, M., Campomayor, C.O., Collado-Hidalgo, A., Cole, S., Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch. Intern. Med. 166:16 (2006), 1756–1762.
54. Kaivanto, K.K., Estlander, A.M., Moneta, G.B., Vanharanta, H., Isokinetic performance in low-back-pain patients – the predictive power of the self-efficacy scale. J. Occup. Rehabil. 5:2 (1995), 87–99.
55. Keller, C., Keller, P., Giralt, M., Hidalgo, J., Pedersen, B.K., Exercise normalises overexpression of TNF-alpha in knockout mice. Biochem. Biophys. Res. Commun. 321:1 (2004), 179–182.
56. Khaodhiar, L., Ling, P.R., Blackburn, G.L., Bistrian, B.R., Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. J. Parenter. Enteral Nutr. 28:6 (2004), 410–415.
57. Koch, A., Zacharowski, K., Boehm, O., Stevens, M., Lipfert, P., von Giesen, H.J., Wolf, A., Freynhagen, R., Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Inflamm. Res. 56:1 (2007), 32–37.
58. Koenker, R., Bassett, G., Regression quantiles. Econometrica 46:1 (1978), 33–50.
59. Kosek, E., Altawil, R., Kadetoff, D., Finn, A., Westman, M., Le Maitre, E., Andersson, M., Jensen-Urstad, M., Lampa, J., Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain–interleukin-8 in fibromyalgia and interleukin-1 beta in rheumatoid arthritis. J. Neuroimmunol. 280 (2015), 49–55.
60. Kraychete, D.C., Sakata, R.K., Issy, A.M., Bacellar, O., Santos-Jesus, R., Carvalho, E.M., Serum cytokine levels in patients with chronic low back pain due to herniated disc: analytical cross-sectional study. Sao Paulo Med. J. 128:5 (2010), 259–262.
61. Kushner, I., Jiang, S.L., Zhang, D.X., Lozanski, G., Samols, D., Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1? Interleukin-6 Type. Cytokines 762 (1995), 102–107.
62. Lewinsohn, P.M., Seeley, J.R., Roberts, R.E., Allen, N.B., Center for epidemiologic studies depression scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol. Aging 12:2 (1997), 277–287.
63. Lotz, M., Interleukin-6. Cancer Invest. 11:6 (1993), 732–742.
64. Mackiewicz, A., Speroff, T., Ganapathi, M.K., Kushner, I., Effects of cytokine combinations on acute phase protein-production in 2 human hepatoma-cell lines. J. Immunol. 146:9 (1991), 3032–3037.
65. Marnell, L., Mold, C., Du Clos, T.W., C-reactive protein: ligands, receptors and role in inflammation. Clin. Immunol. 117:2 (2005), 104–111.
66. Marty, M., Rozenberg, S., Duplan, B., Thomas, P., Duquesnoy, B., Allaert, F., Section Rachis de la Societe Francaise de R. Quality of sleep in patients with chronic low back pain: a case-control study. Eur. Spine J. 17:6 (2008), 839–844.
67. McIntosh, J.K., Jablons, D.M., Mule, J.J., Nordan, R.P., Rudikoff, S., Lotze, M.T., Rosenberg, S.A., In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. J. Immunol. 143:1 (1989), 162–167.
68. McNiff, P.A., Stewart, C., Sullivan, J., Showell, H.J., Gabel, C.A., Synovial fluid from rheumatoid arthritis patients contains sufficient levels of IL-1 beta and IL-6 to promote production of serum amyloid A by Hep3B cells. Cytokine 7:2 (1995), 209–219.
69. Messay, B., Lim, A., Marsland, A.L., Current understanding of the bi-directional relationship of major depression with inflammation. Biol. Mood Anxiety Disord., 2(1), 2012, 4.
70. Miller, A.H., Maletic, V., Raison, C.L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65:9 (2009), 732–741.
71. Motivala, S.J., Sarfatti, A., Olmos, L., Irwin, M.R., Inflammatory markers and sleep disturbance in major depression. Psychosom. Med. 67:2 (2005), 187–194.
72. Naka, T., Nishimoto, N., Kishimoto, T., The paradigm of IL-6: from basic science to medicine. Arthritis Res. 4:Suppl. 3 (2002), S233–242.
73. Nanri, A., Moore, M.A., Kono, S., Impact of C-reactive protein on disease risk and its relation to dietary factors: literature review. Asian Pac. J. Cancer Prev. 8:2 (2007), 167–177.
74. Neta, R., Vogel, S.N., Sipe, J.D., Wong, G.G., Nordan, R.P., Comparison of in vivo effects of human recombinant IL 1 and human recombinant IL 6 in mice. Lymphokine Res. 7:4 (1988), 403–412.
75. Nicholas, M.K., The pain self-efficacy questionnaire: taking pain into account. Eur. J. Pain 11:2 (2007), 153–163.
76. Osman, A., Barrios, F.X., Kopper, B.A., Hauptmann, W., Jones, J., O'Neill, E., Factor structure, reliability, and validity of the pain catastrophizing scale. J. Behav. Med. 20:6 (1997), 589–605.
77. Pal, M., Febbraio, M.A., Whitham, M., From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation. Immunol. Cell Biol. 92:4 (2014), 331–339.
78. Park, H.S., Park, J.Y., Yu, R., Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res. Clin. Pract. 69:1 (2005), 29–35.
79. Pearle, A.D., Scanzello, C.R., George, S., Mandl, L.A., DiCarlo, E.F., Peterson, M., Sculco, T.P., Crow, M.K., Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 15:5 (2007), 516–523.
80. Pengel, L.H., Herbert, R.D., Maher, C.G., Refshauge, K.M., Acute low back pain: systematic review of its prognosis. BMJ, 327(7410), 2003, 323.
81. Pepys, M.B., Baltz, M.L., Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34 (1983), 141–212.
82. Pepys, M.B., Hirschfield, G.M., C-reactive protein: a critical update. J. Clin. Invest. 111:12 (2003), 1805–1812.
83. Pepys, M.B., Hirschfield, G.M., Tennent, G.A., Gallimore, J.R., Kahan, M.C., Bellotti, V., Hawkins, P.N., Myers, R.M., Smith, M.D., Polara, A., Cobb, A.J.A., Ley, S.V., Aquilina, J.A., Robinson, C.V., Sharif, I., Gray, G.A., Sabin, C.A., Jenvey, M.C., Kolstoe, S.E., Thompson, D., Wood, S.P., Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440:7088 (2006), 1217–1221.
84. Petrovsky, N., McNair, P., Harrison, L.C., Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 10:4 (1998), 307–312.
85. Piranfar, M.A., The correlation between high-sensitivity C-reactive protein (hsCRP) serum levels and severity of coronary atherosclerosis. Int. Cardiovasc. Res. J. 8:1 (2014), 6–8.
86. Radloff, L.S., The CES-D scale: a new self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977), 385–401.
87. Rannou, F., Ouanes, W., Boutron, I., Lovisi, B., Fayad, F., Mace, Y., Borderie, D., Guerini, H., Poiraudeau, S., Revel, M., High-sensitivity C-reactive protein in chronic low pack pain with vertebral end-plate modic signal changes. Arthritis Rheum. 57:7 (2007), 1311–1315.
88. Rechardt, M., Shiri, R., Matikainen, S., Viikari-Juntura, E., Karppinen, J., Alenius, H., Soluble IL-1RII and IL-18 are associated with incipient upper extremity soft tissue disorders. Cytokine 54:2 (2011), 149–153.
89. Reihmane, D., Dela, F., Interleukin-6: possible biological roles during exercise. Eur. J. Sport Sci. 14:3 (2014), 242–250.
90. Reihmane, D., Hansen, A.V., Gram, M., Kuhlman, A.B., Norregaard, J., Pedersen, H.P., Lund, M.T., Helge, J.W., Dela, F., Immobilization increases interleukin-6, but not tumour necrosis factor-, release from the leg during exercise in humans. Exp. Physiol. 98:3 (2013), 778–783.
91. Ren, K., Dubner, R., Interactions between the immune and nervous systems in pain. Nat. Med. 16:11 (2010), 1267–1276.
92. Reveille, J.D., Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clin. Rheumatol. 34:6 (2015), 1009–1018.
93. Ridker, P.M., Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:3 (2003), 363–369.
94. Rocha, V.Z., Folco, E.J., Inflammatory concepts of obesity. Int. J. Inflam., 2011, 2011, 529061.
95. Roland, M., Morris, R., A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine (Phila Pa 1976) 8:2 (1983), 141–144.
96. Salazar, J., Martinez, M.S., Chavez, M., Toledo, A., Anez, R., Torres, Y., Apruzzese, V., Silva, C., Rojas, J., Bermudez, V., C-reactive protein: clinical and epidemiological perspectives. Cardiol. Res. Pract., 2014, 2014, 605810.
97. Scheff, J.D., Calvano, S.E., Lowry, S.F., Androulakis, I.P., Modeling the influence of circadian rhythms on the acute inflammatory response. J. Theor. Biol. 264:3 (2010), 1068–1076.
98. Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S.C., Dinarello, C.A., Correlations and interactions in the production of interleukin-6 (Il-6), Il-1, and tumor necrosis factor (Tnf) in human-blood mononuclear-cells – Il-6 suppresses Il-1 and Tnf. Blood 75:1 (1990), 40–47.
99. Singh, T., Newman, A.B., Inflammatory markers in population studies of aging. Ageing Res. Rev. 10:3 (2011), 319–329.
100. Sousa, A., Raposo, F., Fonseca, S., Valente, L., Duarte, F., Goncalves, M., Tuna, D., Paiva, J.A., Measurement of cytokines and adhesion molecules in the first 72 hours after severe trauma: association with severity and outcome. Dis. Markers, 2015, 2015, 747036.
101. Steensberg, A., Keller, C., Starkie, R.L., Osada, T., Febbraio, M.A., Pedersen, B.K., IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 283:6 (2002), E1272–E1278.
102. Steensberg, A., Fischer, C.P., Keller, C., Moller, K., Pedersen, B.K., IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am. J. Physiol. Endocrinol. Metab. 285:2 (2003), E433–E437.
103. Strecker, W., Gebhard, F., Perl, M., Rager, J., Buttenschon, K., Kinzl, L., Beck, A., Biochemical characterization of individual injury pattern and injury severity. Injury Int. J. Care Injured 34:12 (2003), 879–887.
104. Strouse, T.B., The relationship between cytokines and pain/depression. Curr. Pain Headache Rep. 11:2 (2007), 98–103.
105. Sturmer, T., Raum, E., Buchner, M., Gebhardt, K., Schiltenwolf, M., Richter, W., Brenner, H., Pain and high sensitivity C reactive protein in patients with chronic low back pain and acute sciatic pain. Ann. Rheum. Dis. 64:6 (2005), 921–925.
106. Swaak, A.J., van Rooyen, A., Nieuwenhuis, E., Aarden, L.A., Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. Scand. J. Rheumatol. 17:6 (1988), 469–474.
107. Thiele, J.R., Zeller, J., Bannasch, H., Stark, G.B., Peter, K., Eisenhardt, S.U., Targeting C-reactive protein in inflammatory disease by preventing conformational changes. Mediators Inflamm., 2015, 2015, 372432.
108. Tilg, H., Trehu, E., Atkins, M.B., Dinarello, C.A., Mier, J.W., Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:1 (1994), 113–118.
109. Tonkin, L., The pain self-efficacy questionnaire. Aust. J. Physiother., 54(1), 2008, 77.
110. Tsigos, C., Chrousos, G.P., Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 53:4 (2002), 865–871.
111. Ulich, T.R., Yin, S.M., Guo, K.Z., Yi, E.H.S., Remick, D., Delcastillo, J., Intratracheal injection of endotoxin and cytokines. 2. Interleukin-6 and transforming growth-factor-beta inhibit acute-inflammation. Am. J. Pathol. 138:5 (1991), 1097–1101.
112. Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O., Lotsikas, A., Zachman, K., Kales, A., Prolo, P., Wong, M.L., Licinio, J., Gold, P.W., Hermida, R.C., Mastorakos, G., Chrousos, G.P., Circadian interleukin-6 secretion and quantity and depth of sleep. J. Clin. Endocrinol. Metab. 84:8 (1999), 2603–2607.
113. Vgontzas, A.N., Bixler, E.O., Lin, H.M., Prolo, P., Trakada, G., Chrousos, G.P., IL-6 and its circadian secretion in humans. NeuroImmunoModulation 12:3 (2005), 131–140.
114. Volpato, S., Pahor, M., Ferrucci, L., Simonsick, E.M., Guralnik, J.M., Kritchevsky, S.B., Fellin, R., Harris, T.B., Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitior-1 in well-functioning older adults – the health, aging, and body composition study. Circulation 109:5 (2004), 607–612.
115. Waddell, G., Newton, M., Henderson, I., Somerville, D., Main, C.J., A fear-avoidance beliefs questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain 52:2 (1993), 157–168.
116. Wang, H., Schiltenwolf, M., Buchner, M., The role of TNF-alpha in patients with chronic low back pain-a prospective comparative longitudinal study. Clin. J. Pain 24:3 (2008), 273–278.
117. Wang, H., Ahrens, C., Rief, W., Gantz, S., Schiltenwolf, M., Richter, W., Influence of depression symptoms on serum tumor necrosis factor-alpha of patients with chronic low back pain. Arthritis Res. Ther., 12(5), 2010, R186.
118. Watkins, L.R., Maier, S.F., Glia: a novel drug discovery target for clinical pain. Nat. Rev. Drug Discovery 2:12 (2003), 973–985.
119. Wu, Y., Wang, H.W., Ji, S.R., Sui, S., Two-dimensional crystallization of rabbit C-reactive protein monomeric subunits. Acta Crystallogr. Section D Biol. Crystallogr. 59 (2003), 922–926.
120. Wurfel, M.M., Park, W.Y., Radella, F., Ruzinski, J., Sandstrom, A., Strout, J., Bumgarner, R.E., Martin, T.R., Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity. J. Immunol. 175:4 (2005), 2570–2578.
121. Xiao, Y.M., Haynes, W.L., Michalek, J.E., Russell, I.J., Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol. Int. 33:5 (2013), 1259–1264.
122. Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X.F., Achong, M.K., IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101:2 (1998), 311–320.
123. Yousuf, O., Mohanty, B.D., Martin, S.S., Joshi, P.H., Blaha, M.J., Nasir, K., Blumenthal, R.S., Budoff, M.J., High-sensitivity C-reactive protein and cardiovascular disease a resolute belief or an elusive link?. J. Am. Coll. Cardiol. 62:5 (2013), 397–408.
124. Zhang, J.M., An, J., Cytokines, inflammation, and pain. Int. Anesthesiol. Clin. 45:2 (2007), 27–37.
125. Zhang, D., Jiang, S.L., Rzewnicki, D., Samols, D., Kushner, I., The effect of interleukin-1 on C-reactive protein expression in Hep3B cells is exerted at the transcriptional level. Biochem. J. 310:Pt. 1 (1995), 143–148.